|
"dechaphunkul a"的相关文件
显示项目 1-4 / 4 (共1页)
1
每页显示[10|25|50]项目
| 國立成功大學 |
2023 |
Overall Survival with Osimertinib in Resected EGFR-Mutated NSCLC
|
Tsuboi, M.;Herbst, R.S.;John, T.;Kato, T.;Majem, Majem M.;Groh�, C.;Wang, J.;Goldman, J.W.;Lu, S.;Su, W.-C.;De, Marinis F.;Shepherd, F.A.;Lee, K.H.;Le, N.T.;Dechaphunkul, A.;Kowalski, D.;Poole, L.;Bolanos, A.;Rukazenkov, Y.;Wu, Y.-L. |
| 臺大學術典藏 |
2022-09-15T01:08:54Z |
Open-label, phase IIa study of dabrafenib plus trametinib in East Asian patients with advanced BRAF V600-mutant cutaneous melanoma
|
Si L.; Zhang X.; Shin S.J.; Fan Y.; Chia-Chi Lin; Kim T.M.; Dechaphunkul A.; Maneechavakajorn J.; Wong C.S.; Ilankumaran P.; Lee D.-Y.; Gasal E.; Li H.; Guo J. |
| 國立成功大學 |
2021 |
Phase II, Randomized Study of Spartalizumab (PDR001), an Anti-PD-1 Antibody, versus Chemotherapy in Patients with Recurrent/Metastatic Nasopharyngeal Cancer
|
Even, C.;Wang, H.-M.;Li, S.-H.;Ngan, R.K.-C.;Dechaphunkul, A.;Zhang, L.;Yen, C.-J.;Chan, P.C.;Chakrabandhu, S.;Ma, B.B.Y.;Tanasanvimon, S.;Lee, V.H.F.;Lou, P.-J.;Li, Z.;Spira, A.I.;Sukari, A.;Guigay, J.;McCune, S.;Gonzalez-Maffe, J.;Szpakowski, Szpakowski S.;Yao, Yao Y.;Liang, H.;Mataraza, J.;Sechaud, R.;Manenti, L.;Lim, D.W.-T. |
| 國立成功大學 |
2021 |
Clinical and immunologic responses to a B-Cell epitope vaccine in patients with HER2/neu-overexpressing advanced gastric cancer—results from phase Ib trial IMU.ACS.001
|
Wiedermann, U.;Garner-Spitzer, E.;Chao, Y.;Maglakelidze, Maglakelidze M.;Bulat, I.;Dechaphunkul, A.;Arpornwirat, W.;Charoentum, Charoentum C.;Yen, C.-J.;Yau, T.C.;Tanasanvimon, S.;Maneechavakajorn, J.;Sookprasert, A.;Bai, L.-Y.;Chou, W.-C.;Ungtrakul, T.;Drinic, M.;Tobias, J.;Zielinski, C.C.;Chong, L.;Ede, N.J.;Marino, Marino M.T.;Good, A.J. |
显示项目 1-4 / 4 (共1页)
1
每页显示[10|25|50]项目
|
